Laurus Labs Limited (NSE:LAURUSLABS)

India · Delayed Price · Currency is INR

1,166.40

+65.45 (5.94%)

May 4, 2026, 3:29 PM IST

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
Manufacture and Sale of Pharmaceuticals		55.54B	50.41B	60.41B	49.36B	48.14B
Manufacture and Sale of Pharmaceuticals Growth		10.18%	-16.55%	22.39%	2.54%	69.99%
Total		55.54B	50.41B	60.41B	49.36B	48.14B
Total Growth		10.18%	-16.55%	22.39%	2.54%	69.99%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
outside India		38.00B	30.68B	43.67B	35.57B	32.69B
outside India Growth		23.85%	-29.74%	22.78%	8.79%	78.57%
India		17.54B	19.73B	16.74B	13.79B	15.44B
India Growth		-11.09%	17.86%	21.39%	-10.71%	54.28%
Total		55.54B	50.41B	60.41B	49.36B	48.14B
Total Growth		10.18%	-16.55%	22.39%	2.54%	69.99%

Source: S&P Global Market Intelligence.